Cara Therapeutics Inc. buy Needham & Company LLC
Start price
04.04.23
/
50%
€4.32
Target price
04.04.24
€20.09
Performance (%)
-81.49%
End price
05.04.24
€0.80
Summary
This prediction ended on 05.04.24 with a price of €0.80. Massive losses of -81.49% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Needham___Company_LL for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Needham___Company_LL for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.68
23.05.24
23.05.24
€4.61
23.05.25
23.05.25
-45.33%
24.05.25
24.05.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.67
14.05.24
14.05.24
€4.62
14.05.25
14.05.25
-44.43%
15.05.25
15.05.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.75
10.04.24
10.04.24
€4.64
10.04.25
10.04.25
-53.64%
11.04.25
11.04.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.87
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
-57.16%
29.03.25
29.03.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
05.03.24
05.03.24
€4.61
05.03.25
05.03.25
-52.16%
06.03.25
06.03.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.51
22.01.24
22.01.24
€4.59
22.01.25
22.01.25
-27.22%
23.01.25
23.01.25
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.56
18.12.23
18.12.23
€5.50
18.12.24
18.12.24
-46.39%
19.12.24
19.12.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.60
08.08.23
08.08.23
€20.10
08.08.24
08.08.24
-89.19%
09.08.24
09.08.24

